hit counter

Dementia Caregiver Intervention Needed 24 Cultural Adaptations

A 2026 descriptive study documented 24 major cultural adaptations to the New York University Caregiver Intervention-Enhanced Support (NYUCI-ES) for Chinese and Korean American dementia caregivers. The work is not an outcomes report yet; it is a careful map of how an evidence-based caregiver intervention had to change before it could plausibly fit East Asian immigrant …

Read more

Positive Emoji Use Tracked Lower Depression in 120 Students

Low-burden digital phenotyping is appealing because college students already leave daily traces in phones, messages, sleep logs, and voice samples. In Henry et al.’s 120-student study, positive emoji use was the clearest signal compared with GPS and complex voice biomarkers: higher positive emoji use tracked lower depression and anxiety, while speech rate and sleep added …

Read more

Alzheimer’s Blood Biomarker Models Lose Rule-Out Power Across Cohorts

Editorial card showing Alzheimer's blood biomarker model transfer across cohorts with PET scan and blood assay imagery.

A 2026 ADNI/A4 validation study found that Alzheimer’s plasma-biomarker machine-learning models still ranked amyloid PET status well across cohorts, but the practical rule-out number moved hard: negative predictive value fell from 0.831 inside ADNI to 0.644 when the ADNI-trained model was applied to A4.1 Research Highlights 1,707-person ADNI/A4 test: researchers trained amyloid PET prediction models …

Read more

Seletracetam for Seizure Rescue: Non-Benzodiazepine Alternative Revisited

MHD featured image for seletracetam as a possible non-benzodiazepine seizure rescue therapy.

A 2026 CNS Drugs review argues that seletracetam, an abandoned second-generation racetam antiseizure drug, may be unusually well suited for seizure rescue: early oral studies involved 171 participants, photosensitivity responses occurred in 32 of 36 exposures, and one intranasal named-patient use reduced reading-induced spike rate from 3.1/min to 1.6/min without sedation. Research Highlights Rescue-therapy rationale: …

Read more

Household Pesticide 3-PBA Linked to Depression Risk in 6,502 Adults

MHD featured image for household pesticide biomarkers and depression risk.

A 2026 NHANES analysis of 6,502 adults found that urinary 3-PBA, a pyrethroid insecticide metabolite, was modestly associated with depression risk at OR = 1.02 per 1 μg/L, while self-reported household pesticide exposure weakened after full adjustment to OR = 1.43 (95% CI 0.91 to 2.25).1 The calibrated read is biomarker signal first, causal language …

Read more

Neonatal Brain MRI Shows Gyri Are Connectivity Hubs by 38-44 Weeks

MHD featured image for neonatal MRI, cortical gyri, sulci, and early brain connectivity.

A 2026 developing Human Connectome Project analysis of 438 full-term neonates found that the newborn cortex already had an adult-like folding hierarchy: gyri connected most strongly to other gyri, sulci connected most weakly to other sulci, and structure-function coupling shifted near 41 to 42 weeks postmenstrual age.1 Research Highlights Gyri were already high-connectivity hubs: across …

Read more

Lecanemab Blood Biomarkers Rebound Faster Than Amyloid PET After Stopping

Editorial card showing lecanemab maintenance dosing and Alzheimer's blood biomarkers with blood vials, amyloid PET imagery, and biomarker trajectory lines.

Lecanemab blood biomarkers may rebound much faster than amyloid PET after treatment stops: a 2026 PK/PD model estimated that half of the Aβ42/40 treatment effect is lost within 0.5 years, compared with 12.1 years for amyloid PET signal.1 Research Highlights 0.5-year rebound for Aβ42/40: Bhagunde et al. estimated that half of the Aβ42/40 treatment effect …

Read more